PEN: Penumbra Corp Average Forecast Price

Symbol and logo of brand Penumbra Inc (PEN)

The daily price chart for Penumbra, Inc. (PEN) reflects the performance of a company leading the neurosurgery segment through unique clot removal methods. The current indicator is 362.40. The business relies on high-margin sales of revolutionary catheters that have become the global standard of therapy. Success is driven by the synergy between medical professionals and engineers, who are attracted by the social significance of the mission and lucrative stock option programs.

PEN (Penumbra Medical) Consensus Target history from 07/04/2022 to 11/11/2026
Finished products of Penumbra

The consensus forecast aggregates expert expectations for the asset's fair value, defining the long-term capitalization vector and signaling hidden degradation or growth in value before market panic ensues. The trend in the market's average target price allows for an assessment of Penumbra, Inc. (PEN) resilience to supply chain disruptions and the costs of maintaining market share in the thrombectomy systems segment.

Competing companies

DXCM: Forecast Levels Chart|Analyst Consensus Forecast NOVT (Novanta)|Haemonetics Corp (HAE) - Average Forecast Price|INSP - Price Target Chart|PRCT (Procept) - Broker Consensus Forecast|CNMD (CONMED Corporation) - Consensus Target|PLSE: Analyst Forecast Prices|INMD (InMode) - Analyst Consensus Forecast|PMI: Fair Value Consensus|Analyst Consensus Forecast SRDX|SENS - Average Forecast Price|Price Target Chart NeuroPace, Inc. NPCE|Fair Value Consensus TCMD|SANUWAVE - Analyst Consensus Forecast|OM - Analyst Consensus Forecast|smartvest.com (ELMD) - Price Target Chart|Forecast Levels Chart LNSR (LENSAR Inc)|RCEL (AVITA Medical, Inc.) - Analyst Consensus Forecast|Average Forecast Price Profound Medical Corporation PROF|Consensus Target BDMD (Baird Medical Investment)|Analyst Consensus Forecast edap-tms.com (EDAP)|Apyx Medical Corporation - Consensus Target|Analyst Forecast Prices ICCM (IceCure Medical Ltd.)|Pulmonx Corp. - Analyst Consensus Forecast|Analyst Median Target TELA Bio, Inc. TELA|CTSO: Analyst Consensus Forecast|Consensus Target Sensus Healthcare Inc|Consensus Target ZYXI|ECOR: Fair Value Consensus|Price Target Chart Vicarious Surgical Inc. (RBOT)|Consensus Target inspira-technologies.com IINN|Analyst Consensus Forecast ICU (SeaStar Medical)|IRIDEX Corp (IRIX) - Average Forecast Price|Intelligent Bio - Analyst Consensus Forecast|XAIR (Beyond Air, Inc.) - Broker Consensus Forecast|PFSA: Analyst Consensus Forecast|SSKN - Analyst Median Target|GCTK (GlucoTrack) - Analyst Consensus Forecast|Consensus Target NanoVibronix Inc. (NAOV)|Analyst Consensus Forecast VERO|Analyst Consensus Forecast Nuwellis Corp (NUWE)|Price Target Chart Aethlon Medical AEMD|Asensus Surgical Inc - Price Target Chart|AVGR: Consensus Target|Fair Value Consensus BSGM (BioSig Technologies, Inc.)|CUTR: Analyst Consensus Forecast|Average Forecast Price Know Labs Corporation (KNW)|Price Target Chart Inari Medical, Inc.|NVRO - Analyst Target Range|Consensus Target RSLS (ReShape Lifesciences)|Analyst Consensus Forecast Silk Road Medical, Inc. (SILK)